HL Healthcare Ltd

HL Healthcare Ltd specialises in intranasal medical devices. Their portfolio includes intranasal vaccines under the Vaxol brand, which are tailored for specific regional markets such as Germany, Scandinavia, the Baltics, and several Central and Eastern European countries. Additionally, they produce intranasal products for ear health, including Earol for adults and Baby Earol for infants.

HL Healthcare Ltd is based in the United Kingdom. Their headquarters and operations are located in Great Britain, where they develop and manufacture their range of intranasal medical devices.

HL Healthcare Ltd’s devices are listed in the EUDAMED database, which is the European Union’s medical device registry. This platform is used to track and monitor medical devices authorised within the EU, ensuring transparency and compliance with regulatory requirements.

HL Healthcare Ltd’s devices are classified under EU Class IIa. This classification is determined based on factors such as the intended purpose, potential risks, and the body route of administration (intranasal in this case). Class IIa devices are considered to have a moderate risk and require compliance with specific EU regulatory standards and documentation.